Literature DB >> 15176479

Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons.

Myung S Yoo1, Hibiki Kawamata, Dae J Kim, Hong S Chun, Jin H Son.   

Abstract

Neuropathological evidence from both human and experimental models of Parkinson's disease (PD) firmly supports a significant role for oxidative stress (OS) in the death of dopaminergic (DA) neurons in substantia nigra. Largely unknown are the genes underlying selective susceptibility of nigral DA neuron to OS and how they effect nigral DA cell death. The major barriers to high-throughput identification of candidate genes are the paucity of nigral DA neurons as well as the dilution effect of non-DA cells both in primary cultures and brain tissues. To overcome these barriers, we have developed a DA cell line model, SN4741, appropriate for cDNA microarray analysis. Candidate genes were selected from both the microarray analysis and the molecular implication of their pathological mechanisms (i.e., decreased mitochondrial complex I activity and proteasomal dysfunction) of PD. Subsequent secondary validation tests were devised to characterize genes including clone #45 that may underlie selective vulnerability of nigral DA neuron to OS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176479     DOI: 10.1023/b:nere.0000023609.08038.c3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  45 in total

1.  Oxidative stress increases ubiquitin--protein conjugates in synaptosomes.

Authors:  M Ramanathan; M Hassanain; M Levitt; A Seth; J S Tolman; V A Fried; N A Ingoglia
Journal:  Neuroreport       Date:  1999-12-16       Impact factor: 1.837

2.  Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease.

Authors:  P Chan; X Jiang; L S Forno; D A Di Monte; C M Tanner; J W Langston
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

3.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

4.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

5.  An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

Authors:  Todd B Sherer; Ranjita Betarbet; Amy K Stout; Serena Lund; Melisa Baptista; Alexander V Panov; Mark R Cookson; J Timothy Greenamyre
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

6.  Free radical-generated neurotoxicity of 6-hydroxydopamine.

Authors:  R Kumar; A K Agarwal; P K Seth
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

Review 7.  The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Authors:  S Fahn; G Cohen
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

Review 8.  Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate.

Authors:  J W Langston
Journal:  Ann Neurol       Date:  1998-09       Impact factor: 10.422

Review 9.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

10.  Altered proteasomal function in sporadic Parkinson's disease.

Authors:  Kevin St P McNaught; Roger Belizaire; Ole Isacson; Peter Jenner; C Warren Olanow
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  6 in total

Review 1.  Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons.

Authors:  F M J Jacobs; S M Smits; K J M Hornman; J P H Burbach; M P Smidt
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

Review 2.  Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer.

Authors:  Eric E Essick; Flora Sam
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

3.  Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease.

Authors:  Vellareddy Anantharam; Elin Lehrmann; Arthi Kanthasamy; Yongjie Yang; Probal Banerjee; Kevin G Becker; William J Freed; Anumantha G Kanthasamy
Journal:  Neurochem Int       Date:  2007-02-23       Impact factor: 3.921

4.  A preliminary X-ray study of murine Tnfaip8/Oxi-α.

Authors:  Daeun Lee; Mi-Sun Kim; Jimin Park; Gil-Ja Jhon; Jin H Son; Dong Hae Shin
Journal:  Int J Mol Sci       Date:  2014-03-14       Impact factor: 5.923

5.  Mitochondrial dysfunction of immortalized human adipose tissue-derived mesenchymal stromal cells from patients with Parkinson's disease.

Authors:  Hyo Eun Moon; Seung Hee Yoon; Yong Suk Hur; Hyung Woo Park; Ji Young Ha; Kyung-Hee Kim; Jung Hee Shim; Seung Hyun Yoo; Jin H Son; Seung Leal Paek; In Keyoung Kim; Jae Ha Hwang; Dong Gyu Kim; Han-Joon Kim; Beom Seok Jeon; Sung Sup Park; Sun Ha Paek
Journal:  Exp Neurobiol       Date:  2013-12-31       Impact factor: 3.261

6.  Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease.

Authors:  Galba Jean Beppe; Alain Bertrand Dongmo; Harquin Simplice Foyet; Nolé Tsabang; Zenovia Olteanu; Oana Cioanca; Monica Hancianu; Théophile Dimo; Lucian Hritcu
Journal:  BMC Complement Altern Med       Date:  2014-04-30       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.